Scott K Kuwada

Dr. Scott K Kuwada


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2024 in Genes
Verified
Journal Article
Open access
PDF file
DCDavid Coleman
David Coleman
SKScott K Kuwada
Scott K Kuwada
MicroRNAs (miRNAs) are short, non-coding RNA segments that can be detected in a variety of clinical samples, including serum, stool, and urine. While miRNAs were initially known for their effect on post-translational gene expression, the last decade of research has shown them to be promising biomarkers for the detection of many types of cancer. This paper explores the use of miRNA detection as a tool for colorectal cancer (CRC) screening. We discuss the current state of miRNA detection, compare it to the existing CRC screening tools, and highlight the advantages and drawbacks of this approach from a clinical and logistical perspective. Our research finds that miRNA-based tests for CRC show great potential, but that widespread clinical adoption will be conditional on future research overcoming key hurdles.

1 June 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
XLXiufen Li
Xiufen Li
JKJinqiu Kuang
Jinqiu Kuang
YSYi Shen
Yi Shen
MMMartin M. Majer
Martin M. Majer
CNChad C. Nelson
Chad C. Nelson
SKScott K Kuwada
Scott K Kuwada
Because HER-2 has been demonstrated in the nuclei of cancer cells, we hypothesized that it might interact with transcription factors that activate ERBB2 transcription. Macrohistone 2A1 (H2AFY; mH2A1) was found to interact with HER-2 in cancer cells that overexpress HER-2. Of the two human mH2A1 isoforms, mH2A1.2, but not mH2A1.1, interacted with HER-2 in human cancer cell lines. Overexpression of mH2A1.2, but not mH2A1.1, in cancer cells significantly increased HER-2 expression and tumorigenicity. Inhibition of HER-2 kinase activity diminished mH2A1 expression and mH2A1.2-induced ERBB2 transcription in cancer cells. Chromatin immunoprecipitation of mH2A1.2 in cancer cells stably transfected with mH2A1.2 showed enrichment of mH2A1.2 at the HER-2 promoter, suggesting a role for mH2A1.2 in driving HER-2 overexpression. The evolutionarily conserved macro domain of mH2A1.2 was sufficient for the interaction between HER-2 and mH2A1.2 and for mH2A1.2-induced ERBB2 transcription. Within the macro domain of mH2A1.2, a trinucleotide insertion (-EIS-) sequence not found in mH2A1.1 was essential for the interaction between HER-2 and mH2A1.2 as well as mH2A1.2-induced HER-2 expression and cell proliferation.

26 January 2015 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
YSYi Shen
Yi Shen
CZCraig A. Zificsak
Craig A. Zificsak
JSJill Shea
Jill Shea
XLXuegang Lao
Xuegang Lao
OBOana Bollt
Oana Bollt
SKScott K Kuwada
Scott K Kuwada

9 August 2011 in Familial Cancer
Verified
Journal Article
Closed access
PDF file
SKScott K Kuwada
Scott K Kuwada
RBRandall Burt
Randall Burt

1 December 2002
Verified
Journal Article
Closed access
CSCourtney L Scaife
Courtney L Scaife
JKJinqiu Kuang
Jinqiu Kuang
JWJason C Wills
Jason C Wills
DTD Brad Trowbridge
D Brad Trowbridge
PGPhil Gray
Phil Gray
SKScott K Kuwada
Scott K Kuwada

1 October 2020 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
JSJessica Shiosaki
Jessica Shiosaki
MTMaarit Tiirikainen
Maarit Tiirikainen
KPKarolina Peplowska
Karolina Peplowska
DSDavid Shaeffer
David Shaeffer
MMMichio Machida
Michio Machida
SKScott K Kuwada
Scott K Kuwada
Objective: Certain microRNAs (miR) have been previously described to be dysregulated in cancers and can be detected in blood samples. Studies examining the utility of miRs for colon cancer screening have primarily been performed in ethnically homogeneous groups of patients, thus the performance of miRs in multiethnic populations is unknown. Methods: Four miRs were selected that were shown to be aberrantly expressed in the blood or stool of patients with colorectal cancer (CRC) of various ethnicities. In this study, the ability of these miRs to discern early stage CRC was determined in a previously untested multiethnic population of 73 CRC cases and 18 controls. Results: The ratios of non-vesicular to extracellular vesicular levels of miR’s -21, -29a, and -92a were statistically and quantitatively related to CRC stage compared to controls. Conclusion: Serum levels of miR-21, miR-29a and miR-92a were able to significantly detect early stage CRC in a multiethnic and previously untested population.